Moreover, we selected three primary prostate cancer cell lines, LNCaP, PC3 and DU145, which are widely used and representative of advanced and highly tumorigenic prostate cancer to characterize the correlation between EGFR and ZNF216 expression through a Real-Time quantitative RT-PCR analysis [33–36]. This evidence concerns the gene ZFAND5 and prostate carcinoma.